Klinikum Ernst von Bergmann

Kinetics of renal function during induction in newly diagnosed multiple myeloma: Results of two prospective studies by the german myeloma study group dsmm (2021) Bachmann F, Schreder M, Engelhardt M, Langer C, Wolleschak D, Muegge LO, Duerk H, et al. Journal article Aktueller Stand der Durchführung von Nierenersatztherapien auf deutschen Intensivstationen (2021) Willam C, Meersch M, Herbst L, Heering P, Schmitz M, Oppert M, John S, et al. Journal article Curriculum Internistische Intensivmedizin (2021) John S, Riessen R, Karagiannidis C, Janssens U, Busch H, Kochanek M, Michels G, et al. Journal article, Review article Prospective Multicenter BAL Study: Focus real-time PCR (2020) Springer J, Rickerts V, Teschner D, Kessel J, Liebregts T, Cornely A, Schwartz S, et al. Conference contribution Microcirculatory assessment of vascular diseases (2020) Marcoccia A, Klein-Weigel PF, Gschwandtner ME, Wautrecht JC, Matuska J, Rother U, Houben AJHM Journal article, Review article COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry (2020) Rüthrich MM, Giessen-Jung C, Borgmann S, Classen AY, Dolff S, Grüner B, Hanses F, et al. Journal article Qualitätsverbessernde Maßnahmen in der Versorgung von kritisch kranken Intensivpatienten mit Nierenersatztherapie bei akuter Nierenschädigung (2020) Kindgen-Milles D, Heering P, Meersch-Dini M, Schmitz M, Oppert M, John S, Joerres A, et al. Journal article, Review article First results of the “Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)” (2020) Jakob CE, Borgmann S, Duygu F, Behrends U, Hower M, Merle U, Friedrichs A, et al. Journal article Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group (2019) Fuchs M, Goergen H, Kobe C, Kuhnert G, Lohri A, Greil R, Sasse S, et al. Journal article Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108) (2019) Klinghammer K, Gauler T, Dietz A, Grünwald V, Stöhlmacher J, Knipping S, Schroeder M, et al. Journal article